Locally Advanced Solid Tumor
Showing 1 - 25 of 28
ful Mutations in Solid Tumor Characterized by Next Generation
Recruiting
- Solid Tumor
- +13 more
-
Aviano, Pordonone, ItalyIRCCS, Centro di Riferimento Oncologico (CRO) di Aviano
Sep 8, 2023
Cancer, Colorectal Cancer, Solid Tumor Trial in San Antonio (FOG-001)
Recruiting
- Cancer
- +11 more
-
San Antonio, TexasSouth Texas Accelerated Research Therapeutics, LLC
Jun 21, 2023
NSCLC, Pancreatic Cancer, Locally Advanced Solid Tumor Trial in Sydney (HMBD-001, Docetaxel, Nab-paclitaxel)
Not yet recruiting
- Non-Small Cell Lung Cancer
- +3 more
- HMBD-001
- +3 more
-
Sydney, New South Wales, AustraliaGenesisCare North Shore
Jun 16, 2023
Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Canton (repotrectinib (TPX-0005))
Recruiting
- Locally Advanced Solid Tumor
- Metastatic Solid Tumor
- repotrectinib (TPX-0005)
-
Canton, OhioGabrail Cancer Research Center
Apr 25, 2023
Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Providence (TY-2136b)
Not yet recruiting
- Locally Advanced Solid Tumor
- Metastatic Solid Tumor
-
Providence, Rhode IslandRhode Island Hospital, Brown University
Mar 2, 2023
Locally Advanced Solid Tumor, Metastatic Tumor Trial in San Antonio (TST003)
Recruiting
- Locally Advanced Solid Tumor
- Metastatic Tumor
-
San Antonio, TexasNEXT Oncology
Feb 15, 2023
Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in United States (NVL-655)
Recruiting
- Locally Advanced Solid Tumor
- Metastatic Solid Tumor
-
Orange, California
- +13 more
Jan 31, 2023
Cancer, Tumor, Solid, Advanced Solid Tumor Trial in Houston (NTX-1088, Pembrolizumab)
Recruiting
- Cancer
- +4 more
-
Houston, TexasThe University of Texas MD Anderson Cancer Center
Jan 24, 2023
Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in China (VC004)
Recruiting
- Locally Advanced Solid Tumor
- Metastatic Solid Tumor
-
Hefei, Anhui, China
- +20 more
Dec 11, 2022
Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon IL-2 ß/?,
Recruiting
- Advanced Solid Tumor
- +7 more
- TransCon IL-2 β/γ
- +4 more
-
Boston, Massachusetts
- +7 more
Nov 16, 2022
Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Worldwide (NVL-520)
Recruiting
- Locally Advanced Solid Tumor
- Metastatic Solid Tumor
-
Orange, California
- +18 more
Oct 6, 2022
Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon TLR7/8
Recruiting
- Advanced Solid Tumor
- +6 more
- TransCon TLR7/8 Agonist
- Pembrolizumab
-
Duarte, California
- +12 more
Sep 21, 2022
Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in United States (JBI-802)
Recruiting
- Locally Advanced Solid Tumor
- Metastatic Solid Tumor
-
Denver, Colorado
- +3 more
Aug 19, 2022
A Retro-/Prospective, Non-interventional, Cohort Study in Adult
Active, not recruiting
- Solid Tumor, Adult
- +2 more
-
Amiens, France
- +3 more
Jul 22, 2022
HER2-positive, Locally Advanced Solid Tumor, Immunotherapy Trial in Beijing (sintilimab, Trastuzumab, S-1 plus oxaliplatin)
Not yet recruiting
- HER2-positive
- +6 more
- sintilimab
- +2 more
-
Beijing, ChinaCancer Hospital & Institute, Chinese Academy of Medical Sciences
Mar 28, 2022
Unresectable Solid Tumor, Metastatic Solid Tumor, Locally Advanced Solid Tumor Trial in Australia (RC118 for injection)
Recruiting
- Unresectable Solid Tumor
- +2 more
- RC118 for injection
-
Macquarie Park, New South Wales, Australia
- +3 more
Feb 18, 2022
Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)
Recruiting
- Urothelial Carcinoma
- +20 more
- IK-175
- IK-175 and nivolumab
-
Gilbert, Arizona
- +9 more
Feb 3, 2022
Locally Advanced Solid Tumor, Metastatic Cancer Trial in United States (CTX-471)
Recruiting
- Locally Advanced Solid Tumor
- Metastatic Cancer
-
Ocala, Florida
- +9 more
Sep 29, 2021
Metastasis, Locally Advanced Solid Tumor, Recurrent Cancer Trial in Stanford, New York (XRD-0394, Palliative radiotherapy)
Recruiting
- Metastasis
- +2 more
- XRD-0394
- Palliative radiotherapy
-
Stanford, California
- +1 more
Sep 27, 2021